NextCure (NASDAQ:NXTC) Shares Up 3%

NextCure Inc (NASDAQ:NXTC)’s share price shot up 3% during mid-day trading on Friday . The stock traded as high as $81.79 and last traded at $81.78, 16,742 shares traded hands during trading. A decline of 97% from the average session volume of 499,659 shares. The stock had previously closed at $79.41.

Several research firms have recently issued reports on NXTC. Piper Jaffray Companies lifted their price objective on shares of NextCure from $26.00 to $54.00 and gave the stock an “overweight” rating in a research report on Thursday, September 5th. Bank of America lifted their price objective on shares of NextCure from $27.00 to $44.00 and gave the stock a “buy” rating in a research report on Monday, September 9th. Morgan Stanley lifted their price objective on shares of NextCure from $25.00 to $33.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 13th. Finally, Zacks Investment Research raised shares of NextCure from a “hold” rating to a “buy” rating and set a $29.00 price objective for the company in a research report on Wednesday, October 16th.

The firm has a 50-day simple moving average of $32.53. The company has a current ratio of 17.05, a quick ratio of 17.05 and a debt-to-equity ratio of 0.02.

NextCure (NASDAQ:NXTC) last released its quarterly earnings data on Monday, August 12th. The company reported ($0.61) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.46) by ($0.15). The firm had revenue of $1.40 million for the quarter, compared to analyst estimates of $1.50 million. Analysts predict that NextCure Inc will post -1.8 EPS for the current year.

A number of large investors have recently made changes to their positions in NXTC. Matthews International Capital Management LLC acquired a new stake in NextCure during the 2nd quarter worth $6,741,000. Charles Schwab Investment Management Inc. acquired a new stake in NextCure during the 2nd quarter worth $386,000. Fosun International Ltd acquired a new stake in NextCure during the 2nd quarter worth $2,247,000. Northern Trust Corp acquired a new stake in NextCure during the 2nd quarter worth $337,000. Finally, Sofinnova Investments Inc. acquired a new stake in NextCure during the 2nd quarter worth $37,777,000. Hedge funds and other institutional investors own 47.50% of the company’s stock.

About NextCure (NASDAQ:NXTC)

There is no company description available for NextCure Inc

See Also: What are Bollinger Bands?

Receive News & Ratings for NextCure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextCure and related companies with MarketBeat.com's FREE daily email newsletter.